Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2009
11/19/2009US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using
11/19/2009US20090285798 Cd4 mimic peptides and their uses
11/19/2009US20090285796 Mutant jak3 kinase in human leukemia
11/19/2009US20090285785 External Agent for Treatment of Skin Ulcer
11/19/2009US20090285783 Methods and compositions for cancer therapy using a novel adenovirus
11/19/2009US20090285753 Novel haptotactic peptides
11/19/2009CA2725468A1 Novel bacillus thuringiensis gene with lepidopteran activity
11/19/2009CA2724630A1 Targeted coagulation factors and method of using the same
11/19/2009CA2724540A1 Treating dyspnea associated with acute heart failure with relaxin
11/19/2009CA2724198A1 Novel and powerful mhc-class ii petptides derived from survivin
11/19/2009CA2724048A1 Oral preparation
11/19/2009CA2723994A1 Angiogenin-enriched milk fractions
11/19/2009CA2723987A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009CA2723855A1 Long-acting y2 and/or y4 receptor agonists
11/19/2009CA2723822A1 Set of antiangiogenic molecules and use thereof
11/19/2009CA2723621A1 Treatment of hearing and balance impairments using compounds having erythropoietin activity
11/19/2009CA2723170A1 Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009CA2722996A1 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue
11/19/2009CA2722960A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009CA2722959A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009CA2721936A1 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
11/18/2009EP2120050A1 Identification of ligand recognition domains
11/18/2009EP2119794A1 Prevention of incorporation of non-standard amino acids into protein
11/18/2009EP2119787A2 Regulator for flowering time, transgenic plant transformed with the same, and method for regulating flowering time
11/18/2009EP2119785A1 Novel peptides
11/18/2009EP2119778A1 Method for activation of helper t cell and composition for use in the method
11/18/2009EP2119773A1 Lipolytic enzymes from strains of fusarium and acremonium
11/18/2009EP2119728A1 Therapeutic and diagnostic agents
11/18/2009EP2119727A1 Method for production of recombinant human FSH
11/18/2009EP2119726A1 Novel and powerful MHC-class II peptides derived from survivin and neurocan
11/18/2009EP2119448A1 High affinity binding site of HGFR and methods for identification of antagonists thereof
11/18/2009EP2119447A1 Vaccine therapy for choroidal neovascularization
11/18/2009EP2118668A1 Method of determining nt-probnp
11/18/2009EP2118344A2 GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA
11/18/2009EP2118309A2 Diagnostic and therapeutic target for autoimmune diseases and uses thereof
11/18/2009EP2118281A2 Structure-activity relationships
11/18/2009EP2118139A1 Antibodies specific for varicella zoster virus
11/18/2009EP2118137A2 New peptides and polypeptides with improved stability useful in the regeneration of the nervous system
11/18/2009EP2118136A2 Consensus peptide
11/18/2009EP2118135A1 Crtac as a biomarker, therapeutic and diagnostic target
11/18/2009EP2118134A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
11/18/2009EP2118133A2 Amelioration of cellular stress response
11/18/2009EP2118132A1 Transglutaminase variants with improved specificity
11/18/2009EP2118131A1 Glucagon-like protein-1 receptor (glp-1r) agonist compounds
11/18/2009EP2118130A2 Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin ii
11/18/2009EP2118128A2 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
11/18/2009EP2118126A1 Extracting and purifying lipoxygenase
11/18/2009EP2118125A1 Peptide-complement conjugates
11/18/2009EP2118123A1 Stabilized p53 peptides and uses thereof
11/18/2009EP2117620A1 Tropoelastin-based protoelastin biomaterials
11/18/2009EP2117576A1 Methods and compositions related to inhibition of viral entry
11/18/2009EP2117572A2 New fusion molecule based on novel taa variant
11/18/2009EP2117330A1 Process for the preparation of angiogenin
11/18/2009EP1711518B1 Chimpanzee adenovirus vaccine carriers
11/18/2009EP1575990B1 Solid phase bound PNA-dimers and their synthesis
11/18/2009EP1572961B1 Actriib fusion polypeptides and uses therefor
11/18/2009EP1543122B1 Bitter taste receptors
11/18/2009EP1499349B1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/18/2009EP1451552B1 Reagents and methods useful for detecting diseases of the breast
11/18/2009EP1385968B1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/18/2009EP1207873B1 Methods of inhibiting osteoclast activity
11/18/2009EP0960127B1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
11/18/2009EP0914422B1 Mammalian genes involved in viral infection
11/18/2009EP0758904B1 Methods and compositions for the treatment of glomerulonephritis
11/18/2009EP0662133B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
11/18/2009CN101583623A Fusion protein
11/18/2009CN101583622A Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
11/18/2009CN101583621A AMIGO-2 inhibitors for treating, diagnosing or detecting cancer
11/18/2009CN101583371A RNAi methods and compositions for stimulating proliferation of cells with adherent junctions
11/18/2009CN101580880A Gene marker for evaluating genetic ability for carcass weight in bovine and method for evaluating genetic ability for carcass weight using the same
11/18/2009CN101580849A Dna-transfection system for generation of infectious influenza virus
11/18/2009CN101580846A Human cytoglobin for preventing and curing cirrhosis and preparation method thereof
11/18/2009CN101580841A Chilling stress resistant gene PpCDC48-3 of physcomitrella patens and coding protein thereof and vector and cell line containing gene
11/18/2009CN101580840A Chilling stress resistant gene PpHap5a-like of physcomitrella patens and protein and vector thereof
11/18/2009CN101580839A Chilling stress resistant gene Ppubx-including2 of physcomitrella patens and protein and vector thereof
11/18/2009CN101580838A Low-temperature resistant gene Ppviolaxanthin de-epoxidase of physcomitrella patens and protein and vector thereof
11/18/2009CN101580837A Low-temperature resistant gene Pptrigger factor-like protein of physcomitrella patens and protein and vector thereof
11/18/2009CN101580836A Chilling stress resistant gene PpNPL4 family proteinl of physcomitrella patens and protein and vector thereof
11/18/2009CN101580835A Cardiac sodium channel gene SCN5A novel variant and detection method thereof
11/18/2009CN101580834A Human 5-HT7 receptor promoter sequence
11/18/2009CN101580585A Histidine selective water soluble polymer derivative
11/18/2009CN101580547A HASylated polypeptides, especially HASylated erythropoietin
11/18/2009CN101580544A Plate for detecting immunity of cannabis and tetrahydrocannabinol monoclonal antibody through collaurum tag
11/18/2009CN101580543A Transcription factor, namely MYB encoding genes synthesized by plant regulatory anthocyanin
11/18/2009CN101580542A Application of mycobacterium tuberculosis adhesion HBHA in diagnosing and treating tuberculosis
11/18/2009CN101580541A Infectious pancreatic necrosis recombinant VP2 protein antigen and purification method
11/18/2009CN101580540A Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof
11/18/2009CN101580539A Polypeptide for inducing CD4CD25 regulatory T cells and application
11/18/2009CN101580538A WT1-origin HLA-DR-binding antigen peptide
11/18/2009CN101580534A CpTI enzyme-linked immunoassay reagent kit as well as preparation method and application thereof
11/18/2009CN101579522A Novel peptide-based vaccine used for domestic animal and preparation method thereof
11/18/2009CN100560732C Use of a polypeptide
11/18/2009CN100560724C Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
11/18/2009CN100560720C Methods of delivery of exogenous proteins to the cytosol and uses thereof
11/18/2009CN100560719C MELAN-A peptide analogue-virus-like-particle conjugates
11/18/2009CN100560599C Method for preparing phycocyanin and allophycocyanin at same time
11/18/2009CN100560549C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/18/2009CN100560130C Tumor antigen based on products of the tumor suppressor gent WT1
11/17/2009USRE40988 infections caused by HIV-1 or HIV-2; pain; cancers; anorexia nervosa; bulimia; cachexia; obesity; diabetes; asthma; Parkinson's disease; both acute and congestive heart failure; hypotension; hypertension; urinary retention; osteoporosis; angina pectoris; myocardial infarction; ulcers
11/17/2009US7620605 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse
1 ... 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 ... 2916